Showing 1 - 6 results of 6 for search 'Bernhard Kaiser', query time: 0.02s
Refine Results
-
1
-
2
Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy—A Retrospective Bi-Centric Cohort Study by David Lang, Anna Brauner, Florian Huemer, Gabriel Rinnerthaler, Andreas Horner, Romana Wass, Elmar Brehm, Bernhard Kaiser, Richard Greil, Bernd Lamprecht
Published 2021-12-01
Article -
3
First-Line Pembrolizumab Mono- or Combination Therapy of Non-Small Cell Lung Cancer: Baseline Metabolic Biomarkers Predict Outcomes by David Lang, Linda Ritzberger, Vanessa Rambousek, Andreas Horner, Romana Wass, Kaveh Akbari, Bernhard Kaiser, Jürgen Kronbichler, Bernd Lamprecht, Michael Gabriel
Published 2021-12-01
Article -
4
Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Retrospective Comparison Focusing on Pulmonary Toxicity by Romana Wass, Maximilian Hochmair, Bernhard Kaiser, Brane Grambozov, Petra Feurstein, Gertraud Weiß, Raphaela Moosbrugger, Felix Sedlmayer, Bernd Lamprecht, Michael Studnicka, Franz Zehentmayr
Published 2022-06-01
Article -
5
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC by Brane Grambozov, Markus Stana, Bernhard Kaiser, Josef Karner, Sabine Gerum, Elvis Ruznic, Barbara Zellinger, Raphaela Moosbrugger, Michael Studnicka, Gerd Fastner, Felix Sedlmayer, Franz Zehentmayr
Published 2022-01-01
Article -
6
Clinical, imaging, and blood biomarkers to assess 1-year progression risk in fibrotic interstitial lung diseases—Development and validation of the honeycombing, traction bronchiect... by Guangyu Shao, Guangyu Shao, Patricia Hawle, Kaveh Akbari, Kaveh Akbari, Andreas Horner, Andreas Horner, Rainer Hintenberger, Rainer Hintenberger, Bernhard Kaiser, Bernd Lamprecht, Bernd Lamprecht, David Lang, David Lang
Published 2022-11-01
Article